Skip to content

Paradigm Biocapital Advisors LP

Follow

13F filer, CIK 1855655, NEW YORK, NY

Paradigm Biocapital Advisors LP reported $5,028,958,519 across 30 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 77.56% of the portfolio.

Accepted , ingested 13F-HR 0001855655-26-000020

Period
2026-09-30
Reported value
$5.03B
Holdings
30
Top 10 weight
77.56%
New
8
Sold out
6

Part of the filer group Paradigm Biocapital Advisors LP

  • Paradigm BioCapital Advisors GP LLC
  • Paradigm BioCapital International Fund Ltd.
  • Senai Asefaw, M.D.
How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
INSMadded+1,370,000$156M
BBIOnew+2,347,850$154M
MBXadded+1,264,870$74.1M
OBXnew+4,155,214$57.1M
SYREadded+616,672$54.9M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
NUVLexited-5,924,433-$732M
APGEexited-1,576,385-$209M
ALNYexited-480,000-$144M
EYPTexited-2,890,397-$41.3M
TARSreduced-474,274-$37.3M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001855655-26-000020, largest first. % of portfolio is the value over $5,028,958,519, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,553,111 shares; 2025Q1: 6,178,111 shares; 2025Q2: 6,093,291 shares; 2025Q3: 6,223,291 shares; 2025Q4: 6,644,403 shares; 2026Q1: 6,655,703 shares; 2026Q2: 6,361,323 shares; 2026Q3: 6,219,323 shares 6,219,323$1.28B25.38%-142,000Timeline
GMABGENMAB A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 3,816,851 shares; 2025Q4: 7,039,834 shares; 2026Q1: 7,967,836 shares; 2026Q2: 13,133,131 shares; 2026Q3: 14,136,472 shares 14,136,472$504M10.03%+1,003,341Timeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,493,929 shares; 2025Q1: 4,394,556 shares; 2025Q2: 6,142,344 shares; 2025Q3: 6,170,131 shares; 2025Q4: 6,541,210 shares; 2026Q1: 7,365,038 shares; 2026Q2: 10,215,455 shares; 2026Q3: 10,778,665 shares 10,778,665$438M8.7%+563,210Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,527,205 shares; 2025Q1: 2,127,205 shares; 2025Q2: 1,870,445 shares; 2025Q3: 1,467,266 shares; 2025Q4: 1,467,266 shares; 2026Q1: 1,957,266 shares; 2026Q2: 3,840,778 shares; 2026Q3: 4,457,450 shares 4,457,450$397M7.89%+616,672Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 451,359 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,254,488 shares; 2026Q2: 1,325,977 shares; 2026Q3: 2,695,977 shares 2,695,977$308M6.12%+1,370,000Timeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,508,015 shares; 2026Q3: 3,772,885 shares 3,772,885$221M4.4%+1,264,870Timeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 819,660 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,710,316 shares; 2026Q1: 2,320,316 shares; 2026Q2: 2,144,526 shares; 2026Q3: 2,493,507 shares 2,493,507$208M4.13%+348,981Timeline
BLTEBELITE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,114,784 shares; 2026Q2: 1,232,877 shares; 2026Q3: 1,142,123 shares 1,142,123$194M3.86%-90,754Timeline
TARSTARSUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,531,896 shares; 2025Q1: 2,610,197 shares; 2025Q2: 2,976,099 shares; 2025Q3: 2,665,698 shares; 2025Q4: 2,562,154 shares; 2026Q1: 2,562,154 shares; 2026Q2: 2,775,649 shares; 2026Q3: 2,301,375 shares 2,301,375$181M3.6%-474,274Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 3,086,184 shares; 2025Q4: not reported; 2026Q1: 4,009,679 shares; 2026Q2: 6,357,523 shares; 2026Q3: 6,961,546 shares 6,961,546$174M3.45%+604,023Timeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,820,079 shares; 2025Q1: 2,095,079 shares; 2025Q2: 2,741,576 shares; 2025Q3: 2,609,353 shares; 2025Q4: 1,443,102 shares; 2026Q1: 3,148,893 shares; 2026Q2: 6,723,788 shares; 2026Q3: 8,257,672 shares 8,257,672$170M3.38%+1,533,884Timeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 965,764 shares; 2025Q3: 684,277 shares; 2025Q4: 684,277 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,347,850 shares 2,347,850$154M3.07%newTimeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,422,787 shares; 2025Q1: 1,696,481 shares; 2025Q2: 3,372,837 shares; 2025Q3: 3,784,755 shares; 2025Q4: 4,068,020 shares; 2026Q1: 4,793,020 shares; 2026Q2: 2,127,852 shares; 2026Q3: 2,142,852 shares 2,142,852$122M2.42%+15,000Timeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,752,354 shares; 2025Q1: 10,802,354 shares; 2025Q2: 11,907,182 shares; 2025Q3: 13,560,017 shares; 2025Q4: 14,159,095 shares; 2026Q1: 10,392,702 shares; 2026Q2: 9,550,000 shares; 2026Q3: 7,998,257 shares 7,998,257$117M2.33%-1,551,743Timeline
JBIOJADE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,857,405 shares; 2026Q3: 6,053,268 shares 6,053,268$85M1.69%+3,195,863Timeline
TYRATYRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,054,991 shares; 2026Q2: 1,828,607 shares; 2026Q3: 3,510,360 shares 3,510,360$76.8M1.53%+1,681,753Timeline
OLMAOLEMA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 7,304,970 shares; 2025Q1: 6,741,172 shares; 2025Q2: 6,764,172 shares; 2025Q3: 6,794,172 shares; 2025Q4: 7,544,172 shares; 2026Q1: 8,020,576 shares; 2026Q2: 8,670,576 shares; 2026Q3: 8,720,576 shares 8,720,576$75.3M1.5%+50,000Timeline
OBXOBSIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 4,155,214 shares 4,155,214$57.1M1.13%newTimeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 372,869 shares; 2025Q4: not reported; 2026Q1: 545,287 shares; 2026Q2: not reported; 2026Q3: 1,299,199 shares 1,299,199$40.6M0.81%newTimeline
ACHVACHIEVE LIFE SCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 4,951,856 shares; 2026Q3: 4,951,856 shares 4,951,856$40.1M0.8%0Timeline
MANEVERADERMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 525,000 shares; 2026Q2: not reported; 2026Q3: 310,060 shares 310,060$37.6M0.75%newTimeline
ASMBASSEMBLY BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 665,251 shares; 2026Q1: 665,251 shares; 2026Q2: 1,553,748 shares; 2026Q3: 1,553,748 shares 1,553,748$36.5M0.73%0Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,401,217 shares; 2026Q1: 1,701,217 shares; 2026Q2: not reported; 2026Q3: 1,505,769 shares 1,505,769$20.3M0.4%newTimeline
KRSAKORSANA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 613,914 shares 613,914$19.6M0.39%newTimeline
EDITEDITAS MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 5,586,625 shares; 2026Q3: 7,575,140 shares 7,575,140$19.5M0.39%+1,988,515Timeline
COAGHEMAB THERAPEUTICS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 629,347 shares 629,347$19.4M0.39%newTimeline
VORVOR BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,750,000 shares; 2026Q1: 1,750,000 shares; 2026Q2: 1,750,000 shares; 2026Q3: 889,575 shares 889,575$17M0.34%-860,425Timeline
KARDKARDIGAN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 900,000 shares; 2026Q3: 900,000 shares 900,000$13.3M0.26%0Timeline
TCGXTCGX ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 300,000 shares 300,000$3.75M0.07%newTimeline
IVAINVENTIVA SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,000,000 shares; 2026Q1: 4,000,000 shares; 2026Q2: 4,000,000 shares; 2026Q3: 808,176 shares 808,176$2.98M0.06%-3,191,824Timeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
NUVLNUVALENT INC5,924,433$732Mshares
APGEAPOGEE THERAPEUTICS INC1,576,385$209Mshares
ALNYALNYLAM PHARMACEUTICALS INC480,000$144Mshares
EYPTEYEPOINT INC2,890,397$41.3Mshares
MPLTMAPLIGHT THERAPEUTICS INC685,852$24.6Mshares
LXEOLEXEO THERAPEUTICS INC4,175,382$19.4Mshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001855655-26-000020 base2026-11-16